Evidence map›Paper›PMID 39035884›Full record

ArticleACS omega2024

Antihistamines H

Daniel B Roquini, Bruna L Lemes, Amanda L B Kreutz, Sophia C Spoladore, Monique C Amaro, Flavia B Lopes, João Paulo S Fernandes, Josué de Moraes

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Phenotypic Screening of HPharmaceuticals (Basel, Switzerland) · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel B RoquiniNúcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, 07023-070 Guarulhos, SP, Brazil.
Bruna L LemesNúcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, 07023-070 Guarulhos, SP, Brazil.
Amanda L B KreutzNúcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, 07023-070 Guarulhos, SP, Brazil.
Sophia C SpoladoreNúcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, 07023-070 Guarulhos, SP, Brazil.
Monique C AmaroNúcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, 07023-070 Guarulhos, SP, Brazil.
Flavia B LopesDepartamento de Medicina, Universidade Federal de São Paulo, 04023-062 São Paulo, SP, Brazil.
João Paulo S FernandesDepartamento de Ciências Farmacêuticas, Universidade Federal de São Paulo, 09913-030 Diadema, SP, Brazil.ORCID https://orcid.org/0000-0002-9089-273X
Josué de MoraesNúcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, 07023-070 Guarulhos, SP, Brazil.ORCID https://orcid.org/0000-0003-1766-7031

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections caused by parasitic helminths pose significant health concerns for both humans and animals. The limited efficacy of existing drugs underscores the urgent need for novel anthelmintic agents. Given the reported potential of antihistamines against various parasites, including worms, this study conducted a screening of clinically available antihistamines against

Identifiers

PMID39035884
PMCPMC11256074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.